Article
10 Feb 2026
Inside HPE Europe 2025 | Accelerating Value Creation: Mastering Performance Optimization For Exit Success
CONTRIBUTING SINCE MAY 1999
McDermott Will & Schulte
POPULAR TOPICS
Food, Drugs, Healthcare, Life Sciences
Corporate/Commercial Law
Finance and Banking
Technology
Employment and HR
McDermott Will & Schulte are most popular:
- within Cannabis & Hemp, Privacy, Food, Drugs, Healthcare and Life Sciences topic(s)
COMPANY CONTENT
Article
10 Feb 2026
AdvaMed Modernizes Its Code Of Ethics For The Digital Era
Article
10 Feb 2026
Inside HPE Europe 2025 | The Future Of Life Sciences Investment
Article
10 Feb 2026
US Policy Is Disrupting The Global Pharmaceutical Industry
Article
09 Feb 2026
CMS Indefinitely Suspends Submission Of SNF Attachment For Medicare Enrollment
Article
09 Feb 2026
Global M&A Trends: 3 Notable Q4 2025 Cases Out Of The US And UK
Article
09 Feb 2026
Navigating EKRA Compliance: Legal Developments In Percentage-based Marketing Arrangements
Article
09 Feb 2026
Domestically Controlled REIT Ownership Update: Proposed Regulations Would Remove Domestic Corporation Look-through Rule
Article
09 Feb 2026
HPE NYC 2025: Inside The Healthcare Dealmaking Outlook (Video)
Article
09 Feb 2026
Healthcare Regulatory Check-Up Newsletter | September 2025 Recap
Article
09 Feb 2026
UPC Court Of Appeal Significantly Narrows Directors' Personal Liability For Patent Infringement
Article
09 Feb 2026
The UK FCA Consults On Changes To The UK Short Selling Regime
Article
06 Feb 2026
US Treasury's Outbound Investment Security Program: Lessons And Insights
Article
06 Feb 2026
NYDFS Clarifies Expectations For Third-party Cybersecurity Risk Management
Article
06 Feb 2026
HHS GPS V2.0 + HRSA "Strategic Priority Areas": Impact On Federal Grant Recipients Engaged In Pediatric Gender-affirming Care
Article
06 Feb 2026
Hospitals: Prepare Now For Mandatory Provider-Based Attestation Process
Article
05 Feb 2026
SEC Targets Investment Advisory Agreements In Recent Enforcement Settlement
Article
05 Feb 2026
Global M&A Trends: 4 Notable Q3 2025 Cases Out Of The US, EU, And UK
Article
05 Feb 2026
A Deep Dive Into Recent EU And UK Antitrust M&A Shifts: Flexible Jurisdiction And Remedies
Article
05 Feb 2026
3 Takeaways From US Antitrust M&A Activity In Q3 2025
